Search the Newsreel

OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer

WALTHAM, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at key decision moments, today announced the appointment of Sarah Bast …

Sarah Bast Brings More Than Two Decades of Pharma Marketing to OptimizeRx

OptimizeRx (Nasdaq: OPRX) has appointed Sarah Bast as its new Chief Marketing Officer, effective July 23, 2026. Bast brings over two decades of experience in pharmaceutical marketing, specializing in point of care media strategy, analytics, and optimization. In her new role, she will lead …

What Tesla’s Q2 Earnings Reveal About the Real Price of Scaling Optimus

Syntec Optics (NASDAQ:OPTX) Trading Down 1.3% - Time to Sell?

Royce & Associates (OPRX) discloses 1.09M-share passive stake in OptimizeRx

Royce & Associates, LP has disclosed a passive stake of 1,089,398 shares in OptimizeRx Corp (OPRX), representing 5.81% of the company's common stock as of June 30, 2026. Royce & Associates, an indirect majority-owned subsidiary of Franklin Resources, Inc., holds this position for its …

Fifth Third Bancorp Grows Holdings in Option Care Health, Inc. $OPCH

Fifth Third Bancorp significantly increased its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 3,855.4% in the first quarter, now owning 92,082 shares valued at $2.479 million. Other institutional investors have also recently adjusted their positions. The article also details recent insider buying activity …

Optiemus Infracom Share Price Rising 2.64 Percent Today, Among Today's Top Gainers

Option Care Health (OPCH) Expected to Announce Quarterly Earnings on Wednesday

Option Care Health (OPCH) is set to announce its Q2 2026 earnings before market open on Wednesday, July 29th, with analysts forecasting earnings of $0.42 per share and revenue of $1.4181 billion. The company surpassed EPS expectations in the previous quarter, reporting $0.40 against …

Option Care Health, Inc. (NASDAQ:OPCH) Receives Average Rating of "Moderate Buy" from Analysts

Option Care Health, Inc. (NASDAQ:OPCH) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $30.08. While some analysts downgraded the stock or cut price targets, Deutsche Bank maintained a buy rating. Insiders have also been acquiring shares, …

Option Care Health, Inc. $OPCH Shares Acquired by Jennison Associates LLC

Jennison Associates LLC increased its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 4.2% in the first quarter, now owning over 1.2 million shares valued at $32.65 million. Other institutional investors also adjusted their holdings, and insiders purchased over 73,000 shares in the last …

Electro Optic Systems (ASX:EOS) Extends Gains amid Focus on Contract Delivery and Global Defence Demand

1,587,636 Shares in Option Care Health, Inc. $OPCH Acquired by Van Berkom & Associates Inc.

Van Berkom & Associates Inc. has acquired a new stake of 1,587,636 shares in Option Care Health, Inc. (NASDAQ:OPCH), valued at approximately $42.7 million, representing about 1.01% ownership. Other institutional investors have also increased their holdings, with hedge funds now owning around 98.05% of …

Multiple Headwinds Hurt Option Care Health (OPCH)

Madison Small Cap Fund highlighted Option Care Health (OPCH) in its Q2 2026 investor letter, noting a difficult quarter for the company due to the loss of a profitable specialty drug, reimbursement delays, decline in therapy volume, and biosimilar-related pricing pressures. The fund exited …

Electro Optic Systems (ASX:EOS) Posts A$128.46M Revenue—Why This Defence-Technology Stock Remains in Focus

OptimizeRx Corp. (NASDAQ:OPRX) Sees Significant Decline in Short Interest

OptimizeRx Corp. (NASDAQ:OPRX) experienced a significant 39% decrease in short interest in June, bringing the total short interest to 1,129,328 shares. The company's stock rose 2.0% to $6.78, and its recent earnings exceeded expectations with an EPS of $0.14 against a $0.01 consensus. Analysts …

POCI Q2 2026 Earnings: Narrower Loss Reported as Stock Declines Amid Limited Guidance - Earnings Yield Analysis

ECB Stays on War Alert Preparing for Next Rate Hike

(Bloomberg) -- The European Central Bank is likely to hold off on a second interest-rate hike in the coming week while keeping that option open for September. Most Read from Bloomberg FCC Near Rulings Against Disney Over 'The View,' TV Licenses Taylor Farms Pulls …

Option Care Health (NASDAQ:OPCH) Lowered to "Hold" Rating by Stephens

Stephens downgraded Option Care Health (NASDAQ:OPCH) from "strong-buy" to "hold," citing a complex analyst landscape with mixed ratings from other firms. Despite a recent EPS beat, revenue slightly missed estimates, and the stock is trading below its 200-day moving average. Insiders, including the CEO …

Stephens Downgrades Option Care Health(OPCH.US) to Hold Rating, Cuts Target Price to $24

Stephens has downgraded Option Care Health (OPCH.US) from an Overweight to a Hold rating and reduced its price target from $37 to $24. This revision reflects Stephens' adjusted estimates for the company.

Option Care Health : OPCH

This article provides key information for Option Care Health Inc (OPCH), including its stock data, business specialization, and a price target. OPCH is a leading provider of home and alternate site infusion services across the US, offering a wide range of therapies. An analyst …

Stephens downgrades Option Care Health stock rating on execution concerns By Investing.com

Stephens has downgraded Option Care Health (NASDAQ:OPCH) from Outperform to Equal Weight, reducing its price target to $24 from $30 due to execution concerns and diminished near-term visibility for earnings. The firm noted that the investment case has shifted from a growth story to …

OPTION CARE HEALTH INC : STEPHENS CUTS TO EQUAL WEIGHT FROM OVERWEIGHT; CUTS TARGET PRICE TO $24 FROM $30

Stephens downgraded Option Care Health Inc. (OPCH.O) from "Overweight" to "Equal Weight" and reduced its target price from $30 to $24. This change in rating and price target suggests a revised outlook on the company's stock performance by the analyst firm.

Lobbying Update: $80,000 of OPTIMUM COMMUNICATIONS (FORMERLY REPORTING AS ALTICE USA INC.) lobbying was just disclosed

Optimum Communications, formerly Altice USA Inc., recently disclosed $80,000 in lobbying expenditures for Q2 2026. The lobbying efforts focused on issues related to broadband deployment, affordability, programming agreements, marketplace dynamics, and broadcast ownership rules. This information was released in a new Lobbying Disclosure Act …

BIOS5286972 Bond Risk Profile

This article provides a risk profile for the Option Care Health, Inc. 4.375% 31-OCT-2029 bond (BIOS5286972). It highlights key metrics for credit risk assessment, including security level, inflation protection, and issuer rating. The platform encourages users to access exclusive analyst ratings and full data …

Spotting Winners: Optimum Communications (NYSE:OPTU) And Consumer Discretionary - Wireless, Cable and Satellite Stocks In Q1

POCI Q2 2026 Earnings: Loss Narrows but Shares Dip on Uncertain Revenue Outlook - Positive Surprise Momentum

NCLAT directs Aksh Optifibre to deposit Rs 3.33 crore

OPTU Stock Slips As Heavy Losses Clash With Strong Revenue

Syntec Optics expands AI-driven AR optics for warfighter glasses

OPTIMA Forecast — Price Target — Prediction for 2027

OPRX Forecast — Price Target — Prediction for 2027

POCI Q1 2026 Earnings: Narrow Loss as Stock Declines 2.28% - Buyback Announcement Report

Sunny Optical hosts Investor Day to highlight optical market trends

REG - OptiBiotix Health - Result of AGM

Aksh Optifibre promoters declare no new encumbrance in FY26

Syntec Optics lands nearly $4M in orders for DNA sequencing, robotics